Ionis Pharmaceuticals releases its Q3 2026 report, detailing financial performance and strategic initiatives in the pharmaceutical preparations industry.
| Name | IONIS PHARMACEUTICALS INC |
|---|---|
| CIK | 0000874015 |
| Tickers | IONS |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 330336973 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | CA CA |
| Phone | 7609319200 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Ionis Pharmaceuticals releases its Q3 2026 report, detailing financial performance and strategic initiatives in the pharmaceutical preparations industry.
Ionis Pharmaceuticals announces third-quarter financial results, highlighting product launches and adjusting sales guidance amid market dynamics.
Ionis Pharmaceuticals announces a 43.1% reduction in proteinuria with sefaxersen, a potential treatment for IgA nephropathy, based on Phase 3 study results.
Ionis Pharmaceuticals' partner GSK receives FDA approval for HIBSAGO™, a groundbreaking treatment for chronic hepatitis B, enhancing patient care.
2696 filing rows loaded from submissions recent; extra archives: CIK0000874015-submissions-001.json (1688 filings, 1996-06-12 to 2020-07-04).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | 4 | PRIMARY DOCUMENT | 0000874015-26-000273 | 6316 | ||||||
| 2026-11-09 | 10-Q | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) | 0000874015-26-000271 | 000-19125 | 261533999 | 34 | 8251476 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001140361-26-042598 | 000-19125 | 261533751 | 34 | 409246 | 1 | 1 |
| 2026-10-23 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-040631 | 000-19125 | 261481640 | 34 | 186319 | 1 | 1 |
| 2026-10-21 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-040388 | 000-19125 | 261475853 | 34 | 210357 | 1 | 1 |
| 2026-10-19 | 4 | PRIMARY DOCUMENT | 0000874015-26-000267 | 9633 | ||||||
| 2026-10-19 | 4 | PRIMARY DOCUMENT | 0000874015-26-000266 | 9910 | ||||||
| 2026-10-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000263 | 000-19125 | 261466974 | 33 | 4272 | |||
| 2026-09-23 | 8-K | CURRENT REPORT FILING | 7.01,8.01,9.01 | 0001140361-26-037371 | 000-19125 | 261398137 | 34 | 187752 | 1 | 1 |
| 2026-09-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-035802 | 000-19125 | 261362732 | 34 | 181066 | 1 | 1 |
| 2026-09-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-035657 | 000-19125 | 261360083 | 34 | 206926 | 1 | 1 |
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000262 | 5002 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000261 | 4904 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000260 | 4933 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000259 | 4941 | ||||||
| 2026-07-31 | 4 | PRIMARY DOCUMENT | 0000874015-26-000254 | 8263 | ||||||
| 2026-07-31 | S-8 | S-8 | 0001140361-26-030454 | 333-297873 | 261227705 | 33 | 228762 | 1 | 1 | |
| 2026-07-29 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 06-30-2026 | 0000874015-26-000251 | 000-19125 | 261218803 | 34 | 7913959 | 1 | 1 | |
| 2026-07-29 | 8-K | 8-K | 2.02,9.01 | 0001140361-26-029960 | 000-19125 | 261213974 | 34 | 638149 | 1 | 1 |
| 2026-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000247 | 6001 | ||||||
| 2026-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000246 | 5956 | ||||||
| 2026-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000245 | 7511 | ||||||
| 2026-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000244 | 8573 | ||||||
| 2026-07-10 | 8-K | 8-K | 7.01,9.01 | 0001140361-26-028154 | 000-19125 | 261166795 | 34 | 155003 | 1 | 1 |
| 2026-07-09 | 4 | PRIMARY DOCUMENT | 0000874015-26-000239 | 11597 | ||||||
| 2026-07-09 | 4 | PRIMARY DOCUMENT | 0000874015-26-000237 | 8792 | ||||||
| 2026-07-09 | 4 | PRIMARY DOCUMENT | 0000874015-26-000236 | 4950 | ||||||
| 2026-07-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-028092 | 000-19125 | 261165416 | 34 | 191710 | 1 | 1 |
| 2026-07-07 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000227 | 000-19125 | 261159689 | 33 | 4426 | |||
| 2026-07-07 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000226 | 000-19125 | 261159622 | 33 | 5129 | |||
| 2026-07-07 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000225 | 000-19125 | 261159608 | 33 | 5155 | |||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000232 | 9247 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000231 | 9019 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000230 | 9014 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000229 | 17222 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000228 | 9255 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000227 | 9274 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000226 | 9047 | ||||||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000222 | 000-19125 | 261146669 | 33 | 4439 | |||
| 2026-06-30 | 4 | PRIMARY DOCUMENT | 0000874015-26-000218 | 13416 | ||||||
| 2026-06-30 | 4 | PRIMARY DOCUMENT | 0000874015-26-000217 | 4814 | ||||||
| 2026-06-30 | 4 | PRIMARY DOCUMENT | 0000874015-26-000216 | 8863 | ||||||
| 2026-06-26 | 4 | PRIMARY DOCUMENT | 0000874015-26-000212 | 19585 | ||||||
| 2026-06-26 | 4 | PRIMARY DOCUMENT | 0000874015-26-000211 | 6066 | ||||||
| 2026-06-26 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000215 | 000-19125 | 261130803 | 33 | 4960 | |||
| 2026-06-26 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000214 | 000-19125 | 261130798 | 33 | 4442 | |||
| 2026-06-26 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000213 | 000-19125 | 261130781 | 33 | 5004 | |||
| 2026-06-25 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000211 | 000-19125 | 261123466 | 33 | 6587 | |||
| 2026-06-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-026232 | 000-19125 | 261115711 | 34 | 254146 | 1 | 1 |
| 2026-06-16 | 4 | PRIMARY DOCUMENT | 0000874015-26-000208 | 21100 | ||||||
| 2026-06-16 | 4 | PRIMARY DOCUMENT | 0000874015-26-000207 | 9275 | ||||||
| 2026-06-15 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004629 | 000-19125 | 261089357 | 33 | 5059 | |||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000192 | 000-19125 | 261087207 | 33 | 5622 | |||
| 2026-06-12 | 8-K | 8-K | 8.01,9.01 | 0001140361-26-025050 | 000-19125 | 261086034 | 34 | 155246 | 1 | 1 |
| 2026-06-08 | 4 | PRIMARY DOCUMENT | 0000874015-26-000203 | 5787 | ||||||
| 2026-06-08 | 4 | PRIMARY DOCUMENT | 0000874015-26-000202 | 5742 | ||||||
| 2026-06-08 | 3 | PRIMARY DOCUMENT | 0000874015-26-000201 | 3109 | ||||||
| 2026-06-08 | 3 | PRIMARY DOCUMENT | 0000874015-26-000200 | 3064 | ||||||
| 2026-06-08 | 8-K | 8-K | 5.02,5.07,7.01,9.01 | 0001140361-26-024407 | 000-19125 | 261071849 | 34 | 200319 | 1 | 1 |
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0000874015-26-000188 | 9233 | ||||||
| 2026-06-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004164 | 000-19125 | 261048015 | 33 | 4483 | |||
| 2026-05-28 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-023093 | 000-19125 | 261031848 | 34 | 208847 | 1 | 1 |
| 2026-05-15 | 4 | PRIMARY DOCUMENT | 0000874015-26-000185 | 14217 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000462 | 005-41771 | 26983378 | 34 | 7752 | |||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001422849-26-000098 | 005-41771 | 26977707 | 34 | 7492 | |||
| 2026-05-13 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000157 | 000-19125 | 26974660 | 33 | 6165 | |||
| 2026-05-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000183 | 27712 | ||||||
| 2026-05-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000182 | 11789 | ||||||
| 2026-05-04 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000144 | 000-19125 | 26939526 | 33 | 7734 | |||
| 2026-04-30 | 4 | PRIMARY DOCUMENT | 0000874015-26-000179 | 6123 | ||||||
| 2026-04-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000716 | 005-41771 | 26921380 | 34 | 7414 | |||
| 2026-04-29 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 03-31-2026 | 0000874015-26-000177 | 000-19125 | 26914180 | 34 | 6413858 | 1 | 1 | |
| 2026-04-29 | 8-K | 8-K | 2.02,9.01 | 0001140361-26-017637 | 000-19125 | 26910464 | 34 | 551242 | 1 | 1 |
| 2026-04-28 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000138 | 000-19125 | 26907895 | 33 | 6216 | |||
| 2026-04-23 | ARS | ARS | 0001140361-26-016395 | 000-19125 | 26889002 | 34 | 1878255 | |||
| 2026-04-23 | DEFA14A | DEFA14A | 0001140361-26-016391 | 000-19125 | 26888984 | 34 | 2256181 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001140361-26-016388 | 000-19125 | 26888976 | 34 | 13651330 | 1 | 1 | |
| 2026-04-21 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-015801 | 000-19125 | 26876704 | 34 | 214904 | 1 | 1 |
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000172 | 7287 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000171 | 9651 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000170 | 9656 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-26-000169 | 10358 | ||||||
| 2026-04-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000164 | 000-19125 | 26868902 | 33 | 5466 | |||
| 2026-04-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000163 | 000-19125 | 26868892 | 33 | 5457 | |||
| 2026-04-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000162 | 000-19125 | 26868888 | 33 | 6084 | |||
| 2026-04-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000161 | 15180 | ||||||
| 2026-04-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000160 | 5432 | ||||||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000123 | 000-19125 | 26823698 | 33 | 4970 | |||
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001551 | 005-41771 | 26801669 | 34 | 7178 | |||
| 2026-03-24 | 144/A | xsl144X01/primary_doc.xml | 0001972481-26-000116 | 000-19125 | 26787014 | 33 | 5701 | |||
| 2026-03-23 | 4 | PRIMARY DOCUMENT | 0000874015-26-000152 | 5480 | ||||||
| 2026-03-19 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000114 | 000-19125 | 26774133 | 33 | 5026 | |||
| 2026-03-18 | 4 | PRIMARY DOCUMENT | 0000874015-26-000146 | 23078 | ||||||
| 2026-03-16 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000103 | 000-19125 | 26757293 | 33 | 5776 | |||
| 2026-03-11 | 4 | PRIMARY DOCUMENT | 0000874015-26-000144 | 5250 | ||||||
| 2026-03-11 | 4 | PRIMARY DOCUMENT | 0000874015-26-000143 | 23416 | ||||||
| 2026-03-11 | 4 | PRIMARY DOCUMENT | 0000874015-26-000142 | 14078 | ||||||
| 2026-03-10 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000093 | 000-19125 | 26739080 | 33 | 5530 | |||
| 2026-03-09 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000092 | 000-19125 | 26735168 | 33 | 5620 | |||
| 2026-03-09 | 8-K | 8-K | 5.02,7.01,9.01 | 0001140361-26-008340 | 000-19125 | 26733148 | 34 | 182686 | 1 | 1 |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000138 | 13441 | ||||||
| 2026-03-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000137 | 17016 | ||||||
| 2026-03-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000136 | 19380 | ||||||
| 2026-03-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000135 | 26235 | ||||||
| 2026-03-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000134 | 16129 | ||||||
| 2026-03-05 | 4 | PRIMARY DOCUMENT | 0000874015-26-000133 | 26058 | ||||||
| 2026-03-03 | 144/A | xsl144X01/primary_doc.xml | 0001972481-26-000083 | 000-19125 | 26717151 | 33 | 6432 | |||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000082 | 000-19125 | 26717131 | 33 | 4433 | |||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000081 | 000-19125 | 26717088 | 33 | 5513 | |||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000080 | 000-19125 | 26717078 | 33 | 5631 | |||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000078 | 000-19125 | 26716998 | 33 | 4973 | |||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000077 | 000-19125 | 26716986 | 33 | 7791 | |||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000874015-26-000125 | 5446 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000874015-26-000124 | 4768 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000874015-26-000123 | 4797 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000874015-26-000122 | 4804 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000874015-26-000121 | 4868 | ||||||
| 2026-02-26 | 10-K | IONIS PHARMACEUTICALS, INC. 10-K 12-31-2025 | 0000874015-26-000115 | 000-19125 | 26688958 | 34 | 13944684 | 1 | 1 | |
| 2026-02-25 | 8-K | 8-K | 2.02,9.01 | 0001140361-26-006718 | 000-19125 | 26674178 | 34 | 670476 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-26-000248 | 005-41771 | 26637766 | 34 | 7557 | |||
| 2026-02-13 | 4/A | PRIMARY DOCUMENT | 0000874015-26-000112 | 5070 | ||||||
| 2026-02-13 | 4 | PRIMARY DOCUMENT | 0000874015-26-000111 | 7905 | ||||||
| 2026-02-13 | 4 | PRIMARY DOCUMENT | 0000874015-26-000110 | 5174 | ||||||
| 2026-02-13 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000055 | 000-19125 | 26632512 | 33 | 6172 | |||
| 2026-02-11 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000053 | 000-19125 | 26620631 | 33 | 4402 | |||
| 2026-02-10 | 4 | PRIMARY DOCUMENT | 0000874015-26-000106 | 5279 | ||||||
| 2026-02-06 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000045 | 000-19125 | 26607678 | 33 | 5611 | |||
| 2026-02-04 | 4 | PRIMARY DOCUMENT | 0000874015-26-000104 | 15335 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000102 | 7744 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000101 | 7099 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000100 | 7065 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000099 | 7098 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000098 | 7267 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000097 | 7101 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000096 | 7164 | ||||||
| 2026-02-02 | 4 | PRIMARY DOCUMENT | 0000874015-26-000095 | 7800 | ||||||
| 2026-02-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000034 | 000-19125 | 26588170 | 33 | 6199 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000086 | 000-19125 | 26585359 | 33 | 4879 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000085 | 000-19125 | 26585354 | 33 | 4863 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000084 | 000-19125 | 26585344 | 33 | 4924 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000083 | 000-19125 | 26585332 | 33 | 5036 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000082 | 000-19125 | 26585329 | 33 | 4928 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000081 | 000-19125 | 26585326 | 33 | 4872 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000080 | 000-19125 | 26585323 | 33 | 5440 | |||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000078 | 000-19125 | 26585301 | 33 | 4860 | |||
| 2026-01-23 | 4 | PRIMARY DOCUMENT | 0000874015-26-000077 | 5296 | ||||||
| 2026-01-23 | 144/A | xsl144X01/primary_doc.xml | 0001972481-26-000032 | 000-19125 | 26556346 | 33 | 6294 | |||
| 2026-01-22 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000027 | 000-19125 | 26551636 | 33 | 5622 | |||
| 2026-01-21 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000075 | 000-19125 | 26545531 | 33 | 4266 | |||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000073 | 7209 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000072 | 22274 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000071 | 14608 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000070 | 14574 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000069 | 14612 | ||||||
| 2026-01-20 | 4/A | PRIMARY DOCUMENT | 0000874015-26-000068 | 5900 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000067 | 14030 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000066 | 14563 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000065 | 14781 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000064 | 14620 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000063 | 14610 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000062 | 14673 | ||||||
| 2026-01-20 | 4 | PRIMARY DOCUMENT | 0000874015-26-000061 | 22353 | ||||||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000045 | 000-19125 | 26540783 | 33 | 4843 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000043 | 000-19125 | 26540731 | 33 | 4283 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000040 | 000-19125 | 26540725 | 33 | 4327 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000038 | 000-19125 | 26540714 | 33 | 4266 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000037 | 000-19125 | 26540709 | 33 | 4440 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000036 | 000-19125 | 26540707 | 33 | 4329 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000035 | 000-19125 | 26540704 | 33 | 4364 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000034 | 000-19125 | 26540701 | 33 | 4275 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000033 | 000-19125 | 26540699 | 33 | 4263 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000031 | 000-19125 | 26540696 | 33 | 4262 | |||
| 2026-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-26-000030 | 000-19125 | 26540692 | 33 | 5526 | |||
| 2026-01-12 | 8-K | 8-K | 2.02,9.01 | 0001140361-26-000893 | 000-19125 | 26524622 | 34 | 209679 | 1 | 1 |
| 2026-01-09 | 4 | PRIMARY DOCUMENT | 0000874015-26-000029 | 28602 | ||||||
| 2026-01-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001422849-26-000001 | 005-41771 | 26517014 | 34 | 7378 | |||
| 2026-01-07 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000017 | 000-19125 | 26515772 | 33 | 6652 | |||
| 2026-01-07 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-26-000435 | 000-19125 | 26513876 | 34 | 191241 | 1 | 1 |
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000027 | 5717 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000026 | 19974 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000025 | 5724 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000024 | 5690 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000023 | 5718 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000022 | 5822 | ||||||
| 2026-01-06 | 3 | PRIMARY DOCUMENT | 0000874015-26-000021 | 16881 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000020 | 5891 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000019 | 5736 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000018 | 5726 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000017 | 5787 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-26-000016 | 8430 | ||||||
| 2026-01-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000010 | 000-19125 | 26502979 | 33 | 5566 | |||
| 2025-12-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000288 | 7956 | ||||||
| 2025-12-01 | 144/A | xsl144X01/primary_doc.xml | 0001958244-25-004499 | 000-19125 | 251541153 | 33 | 15511 | |||
| 2025-12-01 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004498 | 000-19125 | 251541071 | 33 | 13795 | |||
| 2025-11-28 | 4 | PRIMARY DOCUMENT | 0000874015-25-000286 | 20717 | ||||||
| 2025-11-28 | 4 | PRIMARY DOCUMENT | 0000874015-25-000285 | 8733 | ||||||
| 2025-11-25 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000287 | 000-19125 | 251522897 | 33 | 6150 | |||
| 2025-11-25 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000992 | 000-19125 | 251520981 | 33 | 6484 | |||
| 2025-11-20 | 4 | PRIMARY DOCUMENT | 0000874015-25-000282 | 7348 | ||||||
| 2025-11-20 | 4 | PRIMARY DOCUMENT | 0000874015-25-000281 | 13262 | ||||||
| 2025-11-19 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004467 | 000-19125 | 251500374 | 33 | 5896 | |||
| 2025-11-17 | 8-K | 8-K | 1.01,2.03,3.02,8.01,9.01 | 0001193125-25-284609 | 000-19125 | 251491121 | 34 | 987403 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000512 | 005-41771 | 251483374 | 34 | 7564 | |||
| 2025-11-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-25-041225 | 000-19125 | 251464148 | 34 | 211885 | 1 | 1 |
| 2025-11-07 | 4 | PRIMARY DOCUMENT | 0000874015-25-000278 | 5285 | ||||||
| 2025-11-07 | 4 | PRIMARY DOCUMENT | 0000874015-25-000277 | 24269 | ||||||
| 2025-11-07 | 4/A | PRIMARY DOCUMENT | 0000874015-25-000276 | 13796 | ||||||
| 2025-11-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000272 | 11572 | ||||||
| 2025-11-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000271 | 8653 | ||||||
| 2025-11-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000270 | 25204 | ||||||
| 2025-11-03 | 8-K/A | 8-K/A | 1.01,9.01 | 0001140361-25-040220 | 000-19125 | 251445232 | 34 | 2357469 | 1 | 1 |
| 2025-10-31 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000259 | 000-19125 | 251440859 | 33 | 5013 | |||
| 2025-10-31 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000258 | 000-19125 | 251440850 | 33 | 7233 | |||
| 2025-10-30 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004424 | 000-19125 | 251437421 | 33 | 16954 | |||
| 2025-10-29 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 9-30-2025 | 0000874015-25-000266 | 000-19125 | 251430586 | 34 | 6821854 | 1 | 1 | |
| 2025-10-29 | 8-K | 8-K | 2.02,9.01 | 0001140361-25-039650 | 000-19125 | 251426794 | 34 | 718254 | 1 | 1 |
| 2025-10-16 | 4 | PRIMARY DOCUMENT | 0000874015-25-000262 | 9815 | ||||||
| 2025-10-16 | 4 | PRIMARY DOCUMENT | 0000874015-25-000261 | 5175 | ||||||
| 2025-10-16 | 4 | PRIMARY DOCUMENT | 0000874015-25-000260 | 14468 | ||||||
| 2025-10-16 | 4 | PRIMARY DOCUMENT | 0000874015-25-000259 | 14095 | ||||||
| 2025-10-15 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000250 | 000-19125 | 251394935 | 33 | 6075 | |||
| 2025-10-15 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000249 | 000-19125 | 251394917 | 33 | 5561 | |||
| 2025-10-14 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000248 | 000-19125 | 251392472 | 33 | 4958 | |||
| 2025-10-08 | 4 | PRIMARY DOCUMENT | 0000874015-25-000254 | 5925 | ||||||
| 2025-10-08 | 4 | PRIMARY DOCUMENT | 0000874015-25-000253 | 10666 | ||||||
| 2025-10-08 | 4 | PRIMARY DOCUMENT | 0000874015-25-000252 | 4707 | ||||||
| 2025-10-08 | 4 | PRIMARY DOCUMENT | 0000874015-25-000251 | 5980 | ||||||
| 2025-10-06 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000240 | 000-19125 | 251377919 | 33 | 6775 | |||
| 2025-10-06 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000239 | 000-19125 | 251377879 | 33 | 6808 | |||
| 2025-10-06 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000238 | 000-19125 | 251377861 | 33 | 6176 | |||
| 2025-10-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000246 | 5293 | ||||||
| 2025-10-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000245 | 14734 | ||||||
| 2025-10-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000244 | 13520 | ||||||
| 2025-10-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000243 | 9417 | ||||||
| 2025-10-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000231 | 000-19125 | 251371119 | 33 | 9564 | |||
| 2025-10-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000230 | 000-19125 | 251370906 | 33 | 6209 | |||
| 2025-10-01 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004364 | 000-19125 | 251365742 | 33 | 13313 | |||
| 2025-10-01 | 4 | PRIMARY DOCUMENT | 0000874015-25-000240 | 14057 | ||||||
| 2025-10-01 | 4 | PRIMARY DOCUMENT | 0000874015-25-000239 | 8710 | ||||||
| 2025-10-01 | 4 | PRIMARY DOCUMENT | 0000874015-25-000238 | 8889 | ||||||
| 2025-10-01 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000223 | 000-19125 | 251365162 | 33 | 4978 | |||
| 2025-09-30 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000222 | 000-19125 | 251361188 | 33 | 5598 | |||
| 2025-09-30 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000221 | 000-19125 | 251361049 | 33 | 4599 | |||
| 2025-09-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-25-035634 | 000-19125 | 251328383 | 34 | 190955 | 1 | 1 |
| 2025-09-16 | 4 | PRIMARY DOCUMENT | 0000874015-25-000234 | 8682 | ||||||
| 2025-09-11 | 4 | PRIMARY DOCUMENT | 0000874015-25-000232 | 9418 | ||||||
| 2025-09-11 | 4 | PRIMARY DOCUMENT | 0000874015-25-000231 | 13524 | ||||||
| 2025-09-09 | 4 | PRIMARY DOCUMENT | 0000874015-25-000228 | 8837 | ||||||
| 2025-09-09 | 4 | PRIMARY DOCUMENT | 0000874015-25-000227 | 5343 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000224 | 7903 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000223 | 9490 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000222 | 7151 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000221 | 22854 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000220 | 13637 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000219 | 13637 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000218 | 5275 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000217 | 12121 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000216 | 9490 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000215 | 18174 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000214 | 22938 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000213 | 12160 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000212 | 8655 | ||||||
| 2025-09-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000211 | 10698 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000193 | 4760 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000191 | 4789 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000190 | 4788 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000189 | 4861 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000187 | 4799 | ||||||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000194 | 000-19125 | 251291220 | 33 | 4432 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000193 | 000-19125 | 251290965 | 33 | 5031 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000192 | 000-19125 | 251290627 | 33 | 7334 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000191 | 000-19125 | 251290359 | 33 | 4443 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000190 | 000-19125 | 251290182 | 33 | 6670 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000189 | 000-19125 | 251290058 | 33 | 4951 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000188 | 000-19125 | 251290039 | 33 | 5611 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000715 | 000-19125 | 251289574 | 33 | 4689 | |||
| 2025-09-02 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004293 | 000-19125 | 251287484 | 33 | 13684 | |||
| 2025-09-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000187 | 000-19125 | 251286756 | 33 | 4305 | |||
| 2025-09-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000185 | 000-19125 | 251286178 | 33 | 5016 | |||
| 2025-09-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000184 | 000-19125 | 251286039 | 33 | 4435 | |||
| 2025-09-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000183 | 000-19125 | 251285620 | 33 | 4986 | |||
| 2025-09-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-25-033541 | 000-19125 | 251282925 | 34 | 214032 | 1 | 1 |
| 2025-08-29 | 144 | xsl144X01/primary_doc.xml | 0000048532-25-000002 | 000-19125 | 251279008 | 33 | 4507 | |||
| 2025-08-26 | 4 | PRIMARY DOCUMENT | 0000874015-25-000180 | 5213 | ||||||
| 2025-08-21 | 8-K | 8-K | 7.01,8.01,9.01 | 0001140361-25-032176 | 000-19125 | 251240061 | 34 | 193607 | 1 | 1 |
| 2025-08-20 | 4 | PRIMARY DOCUMENT | 0000874015-25-000178 | 8782 | ||||||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000175 | 000-19125 | 251228238 | 33 | 5547 | |||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000331 | 005-41771 | 251204913 | 34 | 15338 | |||
| 2025-08-08 | 4 | PRIMARY DOCUMENT | 0000874015-25-000176 | 7149 | ||||||
| 2025-08-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000174 | 5274 | ||||||
| 2025-08-06 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000167 | 000-19125 | 251189648 | 33 | 4278 | |||
| 2025-08-05 | 4 | PRIMARY DOCUMENT | 0000874015-25-000172 | 5282 | ||||||
| 2025-08-05 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000165 | 000-19125 | 251185238 | 33 | 4416 | |||
| 2025-08-04 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000157 | 000-19125 | 251180132 | 33 | 9753 | |||
| 2025-08-01 | 4 | PRIMARY DOCUMENT | 0000874015-25-000170 | 8140 | ||||||
| 2025-07-30 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000150 | 000-19125 | 251167902 | 33 | 5013 | |||
| 2025-07-30 | S-8 | S-8 | 0001140361-25-028020 | 333-289093 | 251167454 | 33 | 213990 | 1 | 1 | |
| 2025-07-30 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 6-30-2025 | 0000874015-25-000167 | 000-19125 | 251166815 | 34 | 9531144 | 1 | 1 | |
| 2025-07-30 | 8-K | 8-K | 2.02,9.01 | 0001140361-25-027949 | 000-19125 | 251165048 | 34 | 641961 | 1 | 1 |
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000162 | 7379 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000161 | 7378 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000160 | 7453 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000159 | 7338 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000158 | 7374 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000157 | 8360 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000156 | 7376 | ||||||
| 2025-07-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000155 | 8436 | ||||||
| 2025-07-15 | 4 | PRIMARY DOCUMENT | 0000874015-25-000146 | 5278 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000144 | 8886 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000143 | 8841 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000142 | 8844 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000141 | 8885 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000140 | 8889 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000139 | 8880 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000138 | 8906 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000137 | 8882 | ||||||
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000136 | 8913 | ||||||
| 2025-06-12 | 8-K | 8-K | 5.02,9.01 | 0001140361-25-022267 | 000-19125 | 251041775 | 34 | 168753 | 1 | 1 |
| 2025-06-10 | 8-K | 8-K | 5.07,9.01 | 0001140361-25-022001 | 000-19125 | 251035872 | 34 | 169778 | 1 | 1 |
| 2025-05-19 | 8-K | 8-K | 8.01,9.01 | 0001140361-25-019620 | 000-19125 | 25961490 | 34 | 183591 | 1 | 1 |
| 2025-05-02 | 4 | PRIMARY DOCUMENT | 0000874015-25-000125 | 6023 | ||||||
| 2025-04-30 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 3-31-2025 | 0000874015-25-000123 | 000-19125 | 25894677 | 34 | 8274083 | 1 | 1 | |
| 2025-04-30 | 8-K | 8-K | 2.02,9.01 | 0001140361-25-016562 | 000-19125 | 25892200 | 34 | 524159 | 1 | 1 |
| 2025-04-25 | ARS | ARS | 0001140361-25-015774 | 000-19125 | 25874538 | 34 | 12724082 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0001140361-25-015772 | 000-19125 | 25874515 | 34 | 7437080 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0001140361-25-015771 | 000-19125 | 25874502 | 34 | 13814254 | 1 | 1 | |
| 2025-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000120 | 8948 | ||||||
| 2025-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000119 | 9436 | ||||||
| 2025-04-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000118 | 10220 | ||||||
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000762 | 005-41771 | 25844719 | 34 | 11110 | |||
| 2025-04-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000109 | 000-19125 | 25843728 | 33 | 4261 | |||
| 2025-04-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000108 | 000-19125 | 25843725 | 33 | 4860 | |||
| 2025-04-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000107 | 000-19125 | 25843720 | 33 | 4880 | |||
| 2025-03-13 | 4 | PRIMARY DOCUMENT | 0000874015-25-000105 | 4711 | ||||||
| 2025-03-12 | 8-K | 8-K | 1.01,9.01 | 0001140361-25-008178 | 000-19125 | 25729693 | 34 | 184724 | 1 | 1 |
| 2025-03-11 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000050 | 000-19125 | 25727536 | 33 | 6257 | |||
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000103 | 5452 | ||||||
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000102 | 4774 | ||||||
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000101 | 4803 | ||||||
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000100 | 4802 | ||||||
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000099 | 4810 | ||||||
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0000874015-25-000098 | 4871 | ||||||
| 2025-02-24 | 4 | PRIMARY DOCUMENT | 0000874015-25-000091 | 4685 | ||||||
| 2025-02-19 | 10-K | IONIS PHARMACEUTICALS, INC. 10-K 12-31-2024 | 0000874015-25-000089 | 000-19125 | 25639940 | 34 | 17917973 | 1 | 1 | |
| 2025-02-19 | 8-K | 8-K | 2.02,9.01 | 0001140361-25-005080 | 000-19125 | 25637915 | 34 | 624587 | 1 | 1 |
| 2025-02-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001422849-25-000016 | 005-41771 | 25621208 | 34 | 7295 | |||
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000055 | 005-41771 | 25600296 | 34 | 7560 | |||
| 2025-02-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000085 | 5258 | ||||||
| 2025-02-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000084 | 5287 | ||||||
| 2025-02-04 | 144/A | xsl144X01/primary_doc.xml | 0001972481-25-000021 | 000-19125 | 25589536 | 33 | 8038 | |||
| 2025-02-04 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000020 | 000-19125 | 25589261 | 33 | 7902 | |||
| 2025-02-04 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000019 | 000-19125 | 25589066 | 33 | 7281 | |||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000081 | 7752 | ||||||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000080 | 7108 | ||||||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000079 | 7074 | ||||||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000078 | 7106 | ||||||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000077 | 7277 | ||||||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000076 | 7103 | ||||||
| 2025-02-03 | 4 | PRIMARY DOCUMENT | 0000874015-25-000075 | 7171 | ||||||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000074 | 000-19125 | 25579664 | 33 | 4858 | |||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000073 | 000-19125 | 25579661 | 33 | 4860 | |||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000072 | 000-19125 | 25579274 | 33 | 5453 | |||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000071 | 000-19125 | 25579260 | 33 | 4878 | |||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000070 | 000-19125 | 25579251 | 33 | 5041 | |||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000068 | 000-19125 | 25579197 | 33 | 4930 | |||
| 2025-01-31 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000067 | 000-19125 | 25579190 | 33 | 5541 | |||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000066 | 7230 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000065 | 22281 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000064 | 14617 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000063 | 14584 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000062 | 14622 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000061 | 8659 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000060 | 14788 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000059 | 14614 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000058 | 14630 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000057 | 14048 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000056 | 14681 | ||||||
| 2025-01-17 | 4 | PRIMARY DOCUMENT | 0000874015-25-000055 | 21788 | ||||||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000042 | 000-19125 | 25536749 | 33 | 4857 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000041 | 000-19125 | 25536746 | 33 | 4270 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000040 | 000-19125 | 25536744 | 33 | 4282 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000039 | 000-19125 | 25536743 | 33 | 4943 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000038 | 000-19125 | 25536742 | 33 | 4445 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000037 | 000-19125 | 25536737 | 33 | 4264 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000036 | 000-19125 | 25536734 | 33 | 4279 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000035 | 000-19125 | 25536730 | 33 | 4273 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000034 | 000-19125 | 25536724 | 33 | 4334 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0000874015-25-000033 | 000-19125 | 25536721 | 33 | 4290 | |||
| 2025-01-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000029 | 005-41771 | 25517189 | 34 | 6309 | |||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000032 | 5725 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000031 | 8374 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000030 | 5731 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000029 | 5697 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000028 | 5725 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000027 | 5703 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000026 | 5898 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000018 | 5743 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000017 | 5733 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000016 | 5794 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0000874015-25-000015 | 8436 |
One latest value per concept from companyfacts (454 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 166.55M | 2026-11-03 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 5.28B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | PercentileRank | 90 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 5.59M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.49M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 42.61M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 13.35M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 139.92 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001140361-26-016388 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 75,518.26 | 2026-07-31 | S-8 | 2026-07-31 | 0001140361-26-030454 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 75,518.26 | 2026-07-31 | S-8 | 2026-07-31 | 0001140361-26-030454 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 546.84M | 2026-07-31 | S-8 | 2026-07-31 | 0001140361-26-030454 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-07-31 | S-8 | 2026-07-31 | 0001140361-26-030454 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 27.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 12.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 109,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 116.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 109.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -39.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 3.38B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 10.95M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000874015-25-000089 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | USD | 81.88M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments | USD | 12.04M | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001104659-14-015019 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | -136.62M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions | APIC, Share-based Payment Arrangement, Recognition and Exercise | USD | -19.24M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 132.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 1.86M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 89.75M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 132.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 36.16M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 6.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 4.90M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 2.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | AmortizationOfLeasedAsset | Amortization of Leased Asset | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 231,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001104659-14-015019 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 2.20M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | Assets | Assets | USD | 2.91B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 2.36B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 125,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 10.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 1.64B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 1.87B | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 556,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 4.07M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 1.87B | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0000874015-20-000142 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | USD | 170,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0000874015-20-000142 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 225.96M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0000874015-20-000142 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 596,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-05 | 0000874015-21-000074 | |
| us-gaap | AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1 | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2012-01-31) | USD | -359,000 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-06 | 0001104659-12-054509 | |
| us-gaap | AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2 | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2013-01-31) | USD | 744,000 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001104659-13-060361 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 435.24M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-05 | 0000874015-21-000074 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | USD | 7.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0000874015-20-000142 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 340.62M | 2011-03-31 | 2011 | Q1 | 10-Q | 2011-05-06 | 0001104659-11-026440 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 1.63B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 1.07B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 560.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGain | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | USD | 31.60M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001104659-13-038211 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLosses1 | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | USD | 248,000 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001104659-13-038211 | |
| us-gaap | AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions (Deprecated 2013-01-31) | security | 98 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001104659-13-060361 | |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Investment | 414 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-05 | 0000874015-21-000074 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 478,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 770,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-28 | 0001104659-13-016208 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 296.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 149.19M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 296.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -153.11M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-05 | 0000874015-20-000115 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -75.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/shares_unit | 8.93 | 2006-04-30 | 2013 | FY | 10-K | 2014-03-03 | 0001104659-14-015019 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 8.93 | 2006-04-30 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 4.25M | 2006-04-30 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2011-04-30 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 2.80M | 2020-06-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0000874015-20-000142 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 166.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 166.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 166,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -331.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -294.53M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 1.26B | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 57.44M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 3.49M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 1.18B | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 3.50M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 4.18M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 4.18M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 | |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 88.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 233.36M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 70.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 48.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 78.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 596.36M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0000874015-19-000130 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 141.45M | 2011-12-31 | 2012 | FY | 10-K | 2013-02-28 | 0001104659-13-016208 | |
| us-gaap | CostMethodInvestments | Cost Method Investments | USD | 625,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001104659-14-015019 | |
| us-gaap | CostMethodInvestmentsFairValueDisclosure | Cost Method Investments, Fair Value Disclosure | USD | 625,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001104659-14-015019 | |
| us-gaap | CostmethodInvestmentsOtherThanTemporaryImpairment | Cost-method Investments, Other than Temporary Impairment | USD | 4.40M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | CostMethodInvestmentsRealizedLosses | Cost-method Investments, Realized Losses | USD | 267,000 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-08 | 0001104659-11-061713 |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 9.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 1.11B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | CumulativeEffectOfInitialAdoptionOfNewAccountingPrinciple | Cumulative Effect of Initial Adoption of New Accounting Principle (Deprecated 2011-01-31) | USD | -11.58M | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-03-01 | 0001104659-11-011094 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -1.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 221,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 1.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 2.58M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | DebtAndCapitalLeaseObligations | Debt and Lease Obligation | USD | 839.57M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 178.78M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | DebtInstrumentConvertibleEffectiveInterestRate | Debt Instrument, Convertible, Effective Interest Rate (Deprecated 2013-01-31) | USD | 0.026 | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-03-01 | 0001104659-11-011094 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 500.00M | 2014-10-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.01 | 2014-10-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 101.82M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 1.07B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent | USD | 568.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 8.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 84,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 1.48B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 10.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | Investment | 563 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 1.49B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 10.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible | Decrease in Unrecognized Tax Benefits is Reasonably Possible | USD | 7.60M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 26.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | DeferredRentCredit | Deferred Rent Credit | USD | 17.31M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 106.47M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 72.71M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 38.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 76.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 1.31B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 3.09M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 285.00M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0000874015-19-000130 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 290.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 12.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 361.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 210.46M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 67.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges | USD | 2.37M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 1.24B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxLiabilitiesFinancingArrangements | Deferred Tax Liabilities, Financing Arrangements | USD | 2.92M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 58.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 7.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DeferredTaxLiabilitiesOtherComprehensiveIncome | Deferred Tax Liabilities, Other Comprehensive Income | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 8.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 10.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | Depreciation | Depreciation | USD | 10.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 5.33M | 2008-01-01 | 2008-12-31 | 2010 | FY | 10-K | 2011-03-01 | 0001104659-11-011094 |
| us-gaap | DilutiveSecuritiesEffectOnBasicEarningsPerShareOther | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities | USD | 10.74M | 2018-10-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | USD | 185.66M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax | Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax | USD | -29,000 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | DiscontinuedOperationTaxEffectOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Discontinued Operation | USD | 16.80M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.92 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | 0.15 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.92 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.247 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.024 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 459,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationDeductionsOther | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent | pure | -0.044 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationFdiiAmount | EffectiveIncomeTaxRateReconciliationFdiiAmount | USD | 21.07M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationFdiiPercent | EffectiveIncomeTaxRateReconciliationFdiiPercent | pure | -0.046 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense | Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent | pure | 0.051 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.011 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.051 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.032 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.116 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.047 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -154,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000874015-22-000104 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations | USD | 702,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -199,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 61.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount | Share-based Payment Arrangement, Amount Capitalized | USD | 556,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 7.60M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) | Y | 1.3 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | -4.42M | 2011-12-31 | 2012 | FY | 10-K | 2013-02-28 | 0001104659-13-016208 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationAssets | Equity Method Investment, Summarized Financial Information, Assets (Deprecated 2020-01-31) | USD | 42.88M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationCostOfSales | Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) | USD | 20.93M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets | Equity Method Investment, Summarized Financial Information, Current Assets (Deprecated 2020-01-31) | USD | 38.67M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities | Equity Method Investment, Summarized Financial Information, Current Liabilities (Deprecated 2020-01-31) | USD | 12.85M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) | USD | -7.14M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationLiabilities | Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) | USD | 41.68M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) | USD | -7.60M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets | Equity Method Investment, Summarized Financial Information, Noncurrent Assets (Deprecated 2020-01-31) | USD | 4.21M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities | Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities (Deprecated 2020-01-31) | USD | 28.83M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationRevenue | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) | USD | 13.79M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 77.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | EquitySecuritiesFvNiCost | Equity Securities, FV-NI, Cost | USD | 21.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | EquitySecuritiesFvNiUnrealizedGain | Equity Securities, FV-NI, Unrealized Gain | USD | 0 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0000874015-19-000130 |
| us-gaap | EquitySecuritiesFvNiUnrealizedLoss | Equity Securities, FV-NI, Unrealized Loss | USD | 606,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0000874015-19-000130 |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationFinancingActivities | Excess Tax Benefit from Share-based Compensation, Financing Activities | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationOperatingActivities | Excess Tax Benefit from Share-based Compensation, Operating Activities | USD | 278,000 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | USD | -1.44M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 5.04M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | USD | 3.60M | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 29.61M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000874015-22-000168 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 3.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -12,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000874015-25-000089 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 21.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 20.30M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome | Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income | USD | 19.90M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 72,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-28 | 0001104659-13-016208 |
| us-gaap | GainOnSaleOfInvestments | Gain on Sale of Investments | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 48.62M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 1.30M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -381.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -315.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 1.58M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -89.74M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-05 | 0000874015-21-000074 |
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -84.80M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.85 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.85 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | 185.63M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 1.89 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 1.89 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 2.07M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0000874015-24-000232 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 3.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncomeTaxExpenseBenefitIntraperiodTaxAllocation | Income Tax Expense (Benefit), Intraperiod Tax Allocation | USD | 2,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-07 | 0000874015-14-000095 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | -37,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 46,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | -648,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 93.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 10.81M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationDeductionsOther | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount | USD | 2.41M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | -118,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -79.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationMinorityInterestIncomeExpense | Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount | USD | 2.79M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 4.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 19.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -288,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | 4,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 353,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 12.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 53.50M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 17.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -2.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | -2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 4.59M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | 22.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -46.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | 125,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 36.70M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 |
| us-gaap | IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | USD | 2.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | IncreaseDecreaseInIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Receivable | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 46.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 46.70M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 15.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInOtherEmployeeRelatedLiabilities | Increase (Decrease) in Other Employee-Related Liabilities | USD | -54.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 60.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 10.26M | 2018-10-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | InducedConversionOfConvertibleDebtExpense | Induced Conversion of Convertible Debt Expense | USD | 16.34M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | InterestExpense | Interest Expense | USD | 14.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 106,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 7.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 26.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 2.12M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-04-30 | 0000874015-25-000123 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 28.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 640,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-04-30 | 0000874015-25-000123 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 9.07M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0000874015-18-000105 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 8.74M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-04-30 | 0000874015-25-000123 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 65.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | -1.75M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-05 | 0000874015-15-000057 |
| us-gaap | InvestmentsFairValueDisclosure | Investments, Fair Value Disclosure | USD | 714.82M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-05 | 0000874015-15-000077 | |
| us-gaap | Land | Land | USD | 10.20M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.80M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001140361-15-009498 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 484.82M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 306.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 35.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 34.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 34.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 36.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 36.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 212.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | Liabilities | Liabilities | USD | 2.52B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 2.91B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 435.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | LoansPayableToBank | Loans Payable to Bank | USD | 8.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 1.81B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtAndCapitalLeaseObligations | Long-term Debt and Lease Obligation | USD | 539.11M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | LongTermDebtAndCapitalLeaseObligationsCurrent | Long-term Debt and Lease Obligation, Current | USD | 300.46M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 432.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 300,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 443.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 770.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 60,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 580.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 18.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 1.33B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | LongTermLoansFromBank | Loans Payable to Bank, Noncurrent | USD | 28.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0000874015-21-000056 | |
| us-gaap | MinorityInterestDecreaseFromRedemptions | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests | USD | 544.69M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | MinorityInterestIncreaseFromStockIssuance | Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) | USD | 10.00M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | MinorityInterestPeriodIncreaseDecrease | Noncontrolling Interest, Period Increase (Decrease) | USD | -35.48M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | NetCashProvidedByUsedInContinuingOperations | Net Cash Provided by (Used in) Continuing Operations | USD | 29.54M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | NetCashProvidedByUsedInDiscontinuedOperations | Net Cash Provided by (Used in) Discontinued Operations | USD | 0 | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-03-01 | 0001104659-11-011094 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -329.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 75.55M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 660.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -168.68M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -406.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 122.67M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0000874015-17-000033 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -317.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | 123.55M | 2025-04-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-07-29 | 0000874015-26-000251 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | 127.56M | 2025-04-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-07-29 | 0000874015-26-000251 |
| us-gaap | NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance | Noncontrolling Interest, Increase from Subsidiary Equity Issuance | USD | 30,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 |
| us-gaap | NotesReduction | Notes Reduction | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 661.05M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -350.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 26.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 271.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 9.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 262.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 24.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 228.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 10.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 24.48M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.88M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 1.53M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 1.47M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.60M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.88M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 16.13M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.07 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 17.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 360.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 161.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | 1.63M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-04-30 | 0000874015-25-000123 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | -199,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax | USD | 15.67M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001104659-13-060361 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax | USD | 5.10M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-05 | 0000874015-15-000057 |
| us-gaap | OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax | Other Comprehensive Income (Loss), before Reclassifications, before Tax | USD | 7.37M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-05 | 0000874015-15-000057 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -24.81M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -14,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0000874015-17-000054 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) | USD | -1.16M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001104659-13-060361 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31) | USD | -138,000 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -14.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | USD | 12.80M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 32.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 22.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 20.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 168,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-07 | 0000874015-18-000060 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 805,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities | Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | USD | 880,000 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-08 | 0001104659-11-061713 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities | USD | 880,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001104659-13-038211 |
| us-gaap | PaymentsForHedgeFinancingActivities | Payments for Hedge, Financing Activities | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | PaymentsForProceedsFromInvestments | Payments for (Proceeds from) Investments | USD | -25.53M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000874015-25-000089 |
| us-gaap | PaymentsOfMergerRelatedCostsFinancingActivities | Payments of Merger Related Costs, Financing Activities | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0000874015-21-000166 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 11.20M | 2024-09-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0000874015-24-000232 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000874015-25-000089 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 706.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | PaymentsToAcquireEquitySecuritiesFvNi | PaymentsToAcquireEquitySecuritiesFvNi | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000874015-22-000168 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 5.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | PaymentsToAcquireLand | Payments to Acquire Land | USD | 10.10M | 2010-03-01 | 2010-03-31 | 2015 | FY | 10-K | 2016-02-26 | 0000874015-16-000112 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | PaymentsToAcquireOtherProductiveAssets | Payments to Acquire Other Productive Assets | USD | 3.18M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0000874015-21-000144 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 50.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 110.16M | 2011-01-01 | 2011-03-31 | 2011 | Q1 | 10-Q | 2011-05-06 | 0001104659-11-026440 |
| us-gaap | PaymentsToMinorityShareholders | Payments to Noncontrolling Interests | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.06 | 2017-01-01 | 2017-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0000874015-18-000128 |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000874015-25-000089 |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries | Proceeds from Divestiture of Interest in Consolidated Subsidiaries | USD | 175.00M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 103.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0000874015-24-000116 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | ProceedsFromMinorityShareholders | Proceeds from Noncontrolling Interests | USD | 10.00M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | ProceedsFromRepurchaseOfEquity | Proceeds from (Repurchase of) Equity | USD | 12.60M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 1.42B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecurities | Proceeds from Sale of Available-for-sale Securities | USD | 4.47M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | ProceedsFromSaleOfEquityMethodInvestments | Proceeds from Sale of Equity Method Investments | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | ProceedsFromSaleOfLandHeldForUse | Proceeds from Sale of Land Held-for-use | USD | 10.15M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-28 | 0001104659-13-016208 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 19.60M | 2025-09-01 | 2025-09-30 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 170.33M | 2011-01-01 | 2011-03-31 | 2011 | Q1 | 10-Q | 2011-05-06 | 0001104659-11-026440 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -269.72M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 162.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 21.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ReceivablesLongTermContractsOrPrograms | Receivables, Long-term Contracts or Programs | USD | 62.95M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 | |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 432.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0000874015-20-000142 |
| us-gaap | RepaymentsOfLongTermDebtAndCapitalSecurities | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security | USD | 12.50M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001140361-20-004500 |
| us-gaap | RepaymentsOfLongTermLinesOfCredit | Repayments of Long-term Lines of Credit | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0000874015-22-000079 |
| us-gaap | RepaymentsOfSecuredDebt | Repayments of Secured Debt | USD | 128,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | RepaymentsOfSubordinatedDebt | Repayments of Subordinated Debt | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001140361-17-009823 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 915.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -2.95B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 756.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 60.50M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-05 | 0001104659-13-081234 |
| us-gaap | Revenues | Revenues | USD | 203.33M | 2025-10-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | RoyaltyRevenue | Royalty Revenue (Deprecated 2018-01-31) | USD | 112.54M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 |
| us-gaap | SaleAndLeasebackTransactionGainLossNet | Sale and Leaseback Transaction, Gain (Loss), Net | USD | 4.20M | 2025-09-01 | 2025-09-30 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | SaleOfStockPercentageOfOwnershipAfterTransaction | Sale of Stock, Percentage of Ownership after Transaction | pure | 0.68 | 2017-07-19 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 |
| us-gaap | SaleOfStockPercentageOfOwnershipBeforeTransaction | Sale of Stock, Percentage of Ownership before Transaction | pure | 1 | 2017-01-01 | 2017-07-18 | 2017 | FY | 10-K | 2018-02-28 | 0000874015-18-000047 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 454.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 132.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 | Share-based Payment Arrangement, Expensed and Capitalized, Amount | USD | 132.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | SharePrice | Share Price | USD/shares | 19 | 2013-06-30 | 2013 | Q3 | 10-Q | 2013-11-05 | 0001104659-13-081234 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 43.5 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0000874015-24-000232 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 1.59B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | SquareFootageOfRealEstateProperty | Square Footage of Real Estate Property (Deprecated 2012-01-31) | sqft | 176,000 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001104659-12-014567 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 393.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 315.46M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0000874015-23-000209 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 11.50M | 2024-09-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0000874015-24-000232 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | -15,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 489.12M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationGross | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | USD | 103.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 90.55M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 1.50M | 2020-01-01 | 2020-03-31 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 |
| us-gaap | StockRepurchaseProgramAuthorizedAmount1 | Stock Repurchase Program, Authorized Amount | USD | 125.00M | 2019-09-30 | 2022 | FY | 10-K | 2023-02-22 | 0000874015-23-000105 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 53.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0000874015-19-000045 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 7.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 5.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 137,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 200,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 | |
| us-gaap | ValuationAllowancesAndReservesPeriodIncreaseDecrease | SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) | USD | 107.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0000874015-26-000115 |
| us-gaap | ValuationAllowancesAndReservesReservesOfBusinessesAcquired | SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired | USD | 359,000 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-08 | 0001104659-11-061713 |
| us-gaap | VariableInterestEntityNonconsolidatedCarryingAmountAssets | Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets (Deprecated 2020-01-31) | USD | 18.60M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-09 | 0000874015-15-000082 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 165.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 123.43M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0000874015-17-000054 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 165.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0000874015-26-000271 |